BIOSYNTHESIS OF PLATELET-ACTIVATING-FACTOR IN NORMAL AND INFLAMED HUMAN COLON MUCOSA - EVIDENCE FOR THE INVOLVEMENT OF THE PATHWAY OF PLATELET-ACTIVATING-FACTOR SYNTHESIS DE-NOVO IN INFLAMMATORY BOWEL-DISEASE

被引:14
作者
APPLEYARD, CB [1 ]
HILLIER, K [1 ]
机构
[1] UNIV SOUTHAMPTON, FAC MED, CLIN PHARMACOL GRP, SOUTHAMPTON SO16 7PX, HANTS, ENGLAND
关键词
INFLAMMATORY BOWEL DISEASE; PLATELET-ACTIVATING FACTOR; SYNTHESIS DE NOVO;
D O I
10.1042/cs0880713
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Platelet-activating factor can be synthesized by two distinct biochemical pathways and is degraded by a number of enzymes, the first step of which is deacetylation by a specific acetyl hydrolase. 2. The biochemical pathway of platelet-activating factor synthesis de novo and the first step in platelet-activating factor degradation have been investigated for the first time in incubates of normal human colon mucosa and in inflamed mucosa from patients with inflammatory bowel disease. 3. In the presence of 100 mu mol/l CDP-choline and 100 mu mol/l hexadecyl acetyl glycerol, homogenates from inflamed mucosa synthesized significantly greater platelet-activating factor [851 +/- 574 pmol/mg of protein (mean +/- SEM) in 90 min incubation] than normal mucosa [105 +/- 61 pmol/mg of protein in 90 min incubation] (P < 0,05). 4. Under the same conditions of assay, the percentage turnover to inactive lyso-platelet-activating factor was similar in inflamed mucosa (35.5 +/- 9.4%) and normal mucosa (42.7 +/- 8.5%) in 90 min (P > 0.05). 5. The identity of platelet-activating factor was confirmed by HPLC, by its mobility on TLC and by the ability of WEB 2170, a selective platelet-activating factor receptor antagonist, to block its platelet-aggregatory action. 6. These findings confirm the presence of the pathway for the synthesis de novo of the potently proinflammatory platelet-activating factor in human colon mucosa in inflammatory bowel disease.
引用
收藏
页码:713 / 717
页数:5
相关论文
共 19 条
[1]   CATABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN COLONIC MUCOSA - CALCIUM DEPENDENCE OF THE CATABOLIZING ENZYMES [J].
APPLEYARD, CB ;
HILLIER, K .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) :2503-2509
[2]  
CASALSSTENZEL J, 1990, METHOD ENZYMOL, V187, P455
[3]  
CHILTON FH, 1983, J BIOL CHEM, V258, P6357
[4]   ROLE OF PLATELET-ACTIVATING FACTOR IN ULCERATIVE-COLITIS - ENHANCED PRODUCTION DURING ACTIVE DISEASE AND INHIBITION BY SULFASALAZINE AND PREDNISOLONE [J].
ELIAKIM, R ;
KARMELI, F ;
RAZIN, E ;
RACHMILEWITZ, D .
GASTROENTEROLOGY, 1988, 95 (05) :1167-1172
[5]  
ESPLUGUES JV, 1989, METHOD FIND EXP CLIN, V11, P61
[6]   BIOSYNTHESIS OF PLATELET-ACTIVATING FACTOR IN GLANDULAR GASTRIC-MUCOSA - EVIDENCE FOR THE INVOLVEMENT OF THE DENOVO PATHWAY AND MODULATION BY FATTY-ACIDS [J].
FERNANDEZGALLARDO, S ;
GIJON, MA ;
GARCIA, MD ;
CANO, E ;
CRESPO, MS .
BIOCHEMICAL JOURNAL, 1988, 254 (03) :707-714
[7]   PLATELET-ACTIVATING-FACTOR - AN ENDOGENOUS MEDIATOR FOR BOWEL NECROSIS IN ENDOTOXEMIA [J].
HSUEH, W ;
GONZALEZCRUSSI, F ;
ARROYAVE, JL .
FASEB JOURNAL, 1987, 1 (05) :403-405
[8]   NOVEL ASPECT OF CROHNS-DISEASE - INCREASED CONTENT OF PLATELET-ACTIVATING-FACTOR IN ILEAL AND COLONIC MUCOSA [J].
KALD, B ;
OLAISON, G ;
SJODAHL, R ;
TAGESSON, C .
DIGESTION, 1990, 46 (04) :199-204
[9]   THE METABOLISM OF LYSO-PLATELET-ACTIVATING-FACTOR (1-O-ALKYL-2-LYSO-SN-GLYCERO-3-PHOSPHOCHOLINE) BY A CALCIUM-DEPENDENT LYSOPHOSPHOLIPASE D IN RABBIT KIDNEY MEDULLA [J].
KAWASAKI, T ;
SNYDER, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 920 (01) :85-93
[10]  
LEE TC, 1990, J BIOL CHEM, V265, P9181